BEAT

BEAT

USD

Heartbeam Inc. Common Stock

$1.240-0.030 (-2.362%)

Reaalajas hind

Healthcare
Health Information Services
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.270

Kõrge

$1.285

Madal

$1.220

Maht

0.02M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

41.9M

Tööstusharu

Health Information Services

Riik

United States

Kauplemisstatistika

Keskmine maht

0.10M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $1.17Praegune $1.240Kõrge $3.48

Seotud uudised

BusinessWire

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

First patent significantly advances intellectual property for HeartBeam's credit card-sized ECG device, bolstering both the defensive and offensive moat around the company's core technology Second patent expands the

Vaata rohkem
HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
BusinessWire

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

Board expansion reflects Company's commitment to leadership and innovation in remote cardiac monitoring HeartBeam, Inc., (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing

Vaata rohkem
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth
BusinessWire

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, will hold a conference call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern

Vaata rohkem
HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time
BusinessWire

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

Milestone results formed the basis of HeartBeam's 12-lead ECG synthesis software application submitted to FDA in January 2025 HeartBeam, Inc., (NASDAQ:BEAT), a medical technology company focused on transforming

Vaata rohkem
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
BusinessWire

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

Collaboration brings together two leaders in ambulatory ECG recording and analysis HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized

Vaata rohkem
HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.